SCHEMBL7904396

SCHEMBL7904396

CC(C)C(=O)CNC(=O)c1cccc([N+](=O)[O-])c1N

nearest known ligand 0.47

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CTSD P07339 1/20 0.47
GLA P06280 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
HPGD P15428 5/20 0.43
ALDH1A1 P00352 5/20 0.42
POLB P06746 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
MAPK1 P28482 2/20 0.41
HTT P42858 2/20 0.41
TDP1 Q9NUW8 1/20 0.41
MAPT P10636 1/20 0.41
PKM P14618 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27649297 0.79 CTSD (0.51) CTSDHPGDALDH1A1POLBCYP2C19
SCHEMBL5248182 0.78 SLC6A2 (0.58) CTSDGLASMN1; SMN2HPGDALDH1A1
SCHEMBL7475632 0.76 GLA (0.53) CTSDGLASMN1; SMN2ALDH1A1POLB
SCHEMBL7475644 0.76 GLA (0.53) CTSDGLASMN1; SMN2ALDH1A1POLB
SCHEMBL7908193 0.75 GLA (0.55) CTSDGLASMN1; SMN2HPGDALDH1A1
SCHEMBL7908196 0.73 SMN1; SMN2 (0.55) CTSDGLASMN1; SMN2ALDH1A1POLB
SCHEMBL505223 0.73 TSHR (0.53) CTSDGLASMN1; SMN2ALDH1A1CYP2C19
SCHEMBL8411975 0.72 TSHR (0.51) CTSDGLAALDH1A1CYP2C19CYP1A2
SCHEMBL7908199 0.72 TSHR (0.47) CTSDGLASMN1; SMN2ALDH1A1POLB
SCHEMBL27901687 0.72 TSHR (0.49) CTSDGLASMN1; SMN2ALDH1A1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed